ALKS logo

Alkermes plc (ALKS)

Profile

Full Name

Alkermes plc

Ticker

NASDAQ: ALKS

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

Ireland

IPO

July 16, 1991

Indexes

Not included

Website

http://www.alkermes.com

Employees

1800

Key Details

Price

$26.13(-1.51%)

Market cap

$4.31B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.56B(-6.36% YoY)

Annual EPS

$2.17(+3.33% YoY)

PE ratio

12.50

Next earnings date

Jul 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $26.13
    ALKS price is $26.13

    30-Day Relative Volume

    0.76
    ALKS 30-day relative volume is 0.76

    Price Performance

    Price Most recent change

    -1.51%
    ALKS price was down -1.51% on Jul 25, 2025

    Price YTD change

    -9.14%
    ALKS price is down -9.14% since January 1st

    Price 1-year change

    -6.81%
    ALKS price is down -6.81% year-on-year

    Price 3-year change

    -10.02%
    ALKS price is down -10.02% over the past 3 years

    Price Range

    Price All-time high

    $98.50
    ALKS price is currently -73.47% below its historical high of $98.50

    Price 3-year low

    $21.75
    ALKS price is currently +20.14% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.31B
    ALKS market capitalization is $4.31 billion

    Market cap 3-year change

    -9.67%
    ALKS market capitalization is down -9.67% over the past 3 years

    Market cap All-time high

    $12.03B
    ALKS market capitalization is currently -64.17% below its historical high of $12.03 billion

    Market cap sector rank

    88.13%
    ALKS market capitalization is higher than 88.13% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.14%
    ALKS shares outstanding is up +0.14% year-on-year

    Shares Outstanding 3-Year Change

    +0.39%
    ALKS shares outstanding is up +0.39% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.62
    ALKS beta is 0.62

    200-day SMA

    $30.21
    ALKS price is currently -13.52% below its 200-day simple moving average

    50-day SMA

    $29.70
    ALKS price is currently -12.03% below its 50-day simple moving average

    RSI

    29.30
    ALKS 14-day relative strength index is 29.30

    Volume

    0.76
    ALKS 30-day relative volume is 0.76

    ATR

    $0.83
    ALKS average true range is $0.83

    10-day Historical Volatility

    47.56%
    ALKS 10-day historical volatility is 47.56%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.56B
    ALKS annual revenue is $1.56 billion

    Revenue Analysts estimate

    $1.38B
    ALKS annual revenue is currently +12.62% higher than the consensus analysts' forecast

    Revenue 1-year change

    -6.36%
    ALKS annual revenue is down -6.36% year-on-year

    Revenue Sector rank

    83.31%
    ALKS annual revenue is higher than 83.31% of companies in Healthcare sector

    EPS

    EPS

    $2.17
    ALKS annual earnings per share is $2.17

    EPS Analysts estimate

    $1.70
    ALKS annual earnings per share is currently +27.63% higher than the consensus analysts' forecast

    EPS 1-year change

    +3.33%
    ALKS annual earnings per share is up +3.33% year-on-year

    EPS Sector rank

    92.37%
    ALKS annual earnings per share is higher than 92.37% of companies in Healthcare sector

    Profit

    Gross profit

    $1.31B
    ALKS annual gross profit is $1.31 billion

    Gross margin

    84.25%
    ALKS annual gross profit margin is 84.25%

    Operating profit

    $420.64M
    ALKS annual operating income is $420.64 million

    Operating margin

    27.00%
    ALKS annual operating profit margin is 27.00%

    Net income

    $367.07M
    ALKS annual net profit is $367.07 million

    Net margin

    23.57%
    ALKS annual net profit margin is 23.57%

    Expenses

    Total expenses

    $1.14B
    ALKS annual total expenses is $1.14 billion

    Operating expenses

    $891.66M
    ALKS annual total operating expenses is $891.66 million

    Cost of goods sold

    $245.33M
    ALKS annual cost of goods sold is $245.33 million

    Selling, general & administrative expenses

    $645.24M
    ALKS annual SGA is $645.24 million

    Depreciation and amortization

    $28.53M
    ALKS annual depreciation & amortization is $28.53 million

    Interest expense

    $22.58M
    ALKS annual interest expense is $22.58 million

    Income tax

    $71.61M
    ALKS annual income tax is $71.61 million

    EBIT & EBITDA

    EBIT

    $466.33M
    ALKS annual earnings before interest & taxes is $466.33 million

    EBITDA

    $494.86M
    ALKS annual EBITDA is $494.86 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.06B
    ALKS annual total assets is $2.06 billion

    Non current assets

    $640.21M
    ALKS annual long term assets is $640.21 million

    Current assets

    $1.42B
    ALKS annual total current assets is $1.42 billion

    Cash and cash equivalents

    $291.15M
    ALKS annual cash & cash equivalents is $291.15 million

    Accounts receivable

    $315.33M
    ALKS annual accounts receivable is $315.33 million

    Inventory

    $182.89M
    ALKS annual inventory is $182.89 million

    Liabilities

    Total liabilities

    $590.59M
    ALKS annual total liabilities is $590.59 million

    Long term liabilities

    $125.39M
    ALKS annual total long term liabilities is $125.39 million

    Current liabilities

    $465.20M
    ALKS annual total current liabilities is $465.20 million

    Accounts payable

    $45.63M
    ALKS annual accounts payable is $45.63 million

    Debt

    Total debt

    $75.54M
    ALKS annual total debt is $75.54 million

    Total debt 1-year change

    -79.7%
    ALKS annual total debt is down -79.7% year-on-year

    Long term debt

    $69.37M
    ALKS annual long term debt is $69.37 million

    Short term debt

    $6.17M
    ALKS annual short term debt is $6.17 million

    Equity & Capital

    Shareholders equity

    $1.46B
    ALKS annual stockholders equity is $1.46 billion

    Book value

    $1.46B
    ALKS annual book value is $1.46 billion

    Retained earnings

    -$976.46M
    ALKS annual retained earnings is -$976.46 million

    Working capital

    $950.16M
    ALKS annual working capital is $950.16 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $439.12M
    ALKS annual cash flow from operations is $439.12 million

    Cash from operations 1-year change

    +9.41%
    ALKS annual cash flow from operations is up +9.41% year-on-year

    Cash from investing

    -$111.31M
    ALKS annual cash flow from investing activities is -$111.31 million

    Cash from investing 1-year change

    -308.61%
    ALKS annual cash flow from investing activities is down -308.61% year-on-year

    Cash from financing

    -$494.14M
    ALKS annual cash flow from financing activities is -$494.14 million

    Cash from financing 1-year change

    -70.56%
    ALKS annual cash flow from financing activities is down -70.56% year-on-year

    CAPEX

    CAPEX

    $33.48M
    ALKS annual capital expenditures is $33.48 million

    CAPEX 1-year change

    -30.31%
    ALKS annual capital expenditures is down -30.31% year-on-year

    Free Cash Flow

    Free cash flow

    $405.64M
    ALKS annual free cash flow is $405.64 million

    Free cash flow 1-year change

    +14.81%
    ALKS annual free cash flow is up +14.81% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    84.25%
    ALKS annual gross profit margin is 84.25%

    Operating margin

    27.00%
    ALKS annual operating profit margin is 27.00%

    Net margin

    23.57%
    ALKS annual net profit margin is 23.57%

    ROA & ROE

    ROA

    17.51%
    ALKS annual return on assets is 17.51%

    ROE

    27.52%
    ALKS annual return on equity is 27.52%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    12.50
    ALKS price to earnings ratio is 12.50

    PE ratio Sector rank

    20.75%
    ALKS price to earnings ratio is higher than 20.75% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.85
    ALKS price to book ratio is 2.85

    PB ratio Sector rank

    65.26%
    ALKS price to book ratio is higher than 65.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.85
    ALKS price to sales ratio is 2.85

    PS ratio Sector rank

    48.27%
    ALKS price to sales ratio is higher than 48.27% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.98B
    ALKS enterprise value is $3.98 billion

    Enterprise value Sector rank

    86.24%
    ALKS enterprise value is higher than 86.24% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    8.53
    ALKS EV/EBITDA is 8.53

    EV/EBITDA Sector rank

    80.9%
    ALKS EV/EBITDA is higher than 80.9% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.04
    ALKS annual current ratio is 3.04

    Quick ratio

    2.65
    ALKS annual quick ratio is 2.65

    Leverage

    Debt to equity

    0.00
    ALKS annual debt to equity ratio is 0.00

    Interest coverage ratio

    20.65
    ALKS annual interest coverage ratio is 20.65

    Risk & Stability

    Piotroski F-Score

    8
    ALKS piotroski f-score is 8

    Altman Z-Score

    5.77
    ALKS altman z-score is 5.77

    Analyst ratings

    Recent major analysts updates

    Jul 21, 25 Needham
    Buy
    Jul 21, 25 HC Wainwright & Co.
    Neutral
    Jul 15, 25 Goldman Sachs
    Buy
    Jun 17, 25 UBS
    Buy
    May 28, 25 Needham
    Buy
    May 2, 25 RBC Capital
    Sector Perform
    May 2, 25 Baird
    Outperform
    Apr 28, 25 UBS
    Neutral
    Mar 27, 25 Deutsche Bank
    Buy
    Mar 13, 25 RBC Capital
    Sector Perform

    Institutional Ownership

    Screeners with ALKS included

    Growing Shares Outstanding
    Mid cap stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Alkermes plc?
    • Does Alkermes plc pay dividends?
    • What sector is Alkermes plc in?
    • What industry is Alkermes plc in?
    • What country is Alkermes plc based in?
    • When did Alkermes plc go public?
    • Is Alkermes plc in the S&P 500?
    • Is Alkermes plc in the NASDAQ 100?
    • Is Alkermes plc in the Dow Jones?
    • When was Alkermes plc's last earnings report?
    • When does Alkermes plc report earnings?

    What is the ticker symbol for Alkermes plc?

    The ticker symbol for Alkermes plc is NASDAQ:ALKS

    Does Alkermes plc pay dividends?

    No, Alkermes plc does not pay dividends

    What sector is Alkermes plc in?

    Alkermes plc is in the Healthcare sector

    What industry is Alkermes plc in?

    Alkermes plc is in the Specialty & Generic Drug Manufacturers industry

    What country is Alkermes plc based in?

    Alkermes plc is headquartered in Ireland

    When did Alkermes plc go public?

    Alkermes plc's initial public offering (IPO) was on July 16, 1991

    Is Alkermes plc in the S&P 500?

    No, Alkermes plc is not included in the S&P 500 index

    Is Alkermes plc in the NASDAQ 100?

    No, Alkermes plc is not included in the NASDAQ 100 index

    Is Alkermes plc in the Dow Jones?

    No, Alkermes plc is not included in the Dow Jones index

    When was Alkermes plc's last earnings report?

    Alkermes plc's most recent earnings report was on May 1, 2025

    When does Alkermes plc report earnings?

    The next expected earnings date for Alkermes plc is July 29, 2025
    On this page